The patient was diagnosed with systemic lupus erythematosus before medication. Subsequently, the patient was treated with hormone drugs, but had the prominent facial erythema. One year later, the patient began using CHA for injection alone. After 1 year and 1 month of medication, a follow-up examination showed that the facial erythema had basically disappeared and immune indicators were essentially normal. Currently, the patient has recovered to normal, without recurrence of facial erythema. The administration of CHA for injection has been discontinued.